Voyager co-founder Steven Paul steps down from CEO seat; Alnylam enters final stretch at the FDA with patisiran
→ Voyager Therapeutics $VYGR is hunting for a new CEO as co-founder and current chief executive Steven Paul …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
